204 related articles for article (PubMed ID: 33831733)
1. Promotive effects of HOXA10 antisense RNA on the stemness of oral squamous cell carcinoma stem cells through a microRNA-29a/MCL-1/phosphatidyl inositol 3-kinase/protein kinase B axis.
Wang D
Arch Oral Biol; 2021 Jun; 126():105114. PubMed ID: 33831733
[TBL] [Abstract][Full Text] [Related]
2. Circ_0058063 Contributed to Oral Squamous Cell Carcinoma Development by Sponging miR-145 and Regulating PI3K/AKT Pathway.
Zhou J; Jin S
Mol Biotechnol; 2023 Dec; 65(12):2049-2060. PubMed ID: 36928742
[TBL] [Abstract][Full Text] [Related]
3. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
Li B; Lv Y; Zhang C; Xiang C
J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
5. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
6. Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor.
Yan X; Cong B; Chen Q; Liu L; Luan X; Du J; Cao M
J Int Med Res; 2020 Aug; 48(8):300060520934254. PubMed ID: 32776855
[TBL] [Abstract][Full Text] [Related]
7. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression.
Zhang G; Wang H; Liu G; Huang J
Pathol Res Pract; 2024 Jan; 253():155021. PubMed ID: 38103366
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
9. microRNA-17 is a tumor suppressor in oral squamous cell carcinoma and is repressed by LSD1.
Wangzhou K; Fu W; Li M; Lu Z; Lai Z; Liu C; Tan Y; Hao C
Oral Dis; 2023 Mar; 29(2):491-504. PubMed ID: 34152066
[TBL] [Abstract][Full Text] [Related]
10. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
[TBL] [Abstract][Full Text] [Related]
12. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
14. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
Chi H
Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
[TBL] [Abstract][Full Text] [Related]
15. Importin 7 enhances protective autophagy induced by nuclear translocation of homeobox A10 in oral squamous cell carcinoma.
Chen S; Pan J
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):241-247. PubMed ID: 38650127
[TBL] [Abstract][Full Text] [Related]
16. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
[TBL] [Abstract][Full Text] [Related]
17. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
[TBL] [Abstract][Full Text] [Related]
18.
Huang C; Wang L; Song H; Wu C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
[No Abstract] [Full Text] [Related]
19. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
Li C; Lin XF; Wang JN; Ren XS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
[TBL] [Abstract][Full Text] [Related]
20. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
